• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Nvidia teams up with Abridge to build AI model for healthcare: report

by June 11, 2026
written by June 11, 2026

Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology companies seeking to apply AI tools across the healthcare industry.

According to a report by The Wall Street Journal, Nvidia and Abridge are developing an AI model specifically designed for clinical conversations between doctors and patients.

The model will be deployed exclusively within Abridge’s platform and is intended to improve medical documentation, clinical decision support, and other healthcare workflows.

Nvidia is already an investor in the Pittsburgh-based startup, which has emerged as one of the leading providers of AI-powered note-taking tools for healthcare professionals.

Focus on clinical intelligence

The new model will be built using Nvidia’s Nemotron family of open AI models and then customized using Abridge’s healthcare expertise and clinical data.

Kimberly Powell, Nvidia’s vice president of healthcare, said the partnership reflects a broader effort to adapt AI models for specialized industries.

“There’s an opportunity now to take these models and adapt them with this clinical intelligence at a much earlier stage of model development,” Powell said.

Unlike general-purpose AI models, the healthcare-focused system is being trained to understand the nuances of doctor-patient interactions, medical terminology and clinical decision-making.

Powell said the collaboration also demonstrates how Nvidia’s open models can be tailored for sectors such as drug discovery, medical devices, and digital health.

“Nvidia has been known to be the AI company that works with every other AI company,” Powell added.

Healthcare becomes the next AI battleground

The announcement comes amid a broader race among technology firms to build healthcare-focused AI products.

Last week, Microsoft unveiled a collaboration with Mayo Clinic aimed at creating a healthcare-specific AI model trained on clinical data.

OpenAI and Anthropic have also introduced healthcare offerings targeted at both consumers and medical professionals.

The growing interest reflects the size of the healthcare market and the potential for AI to reduce administrative burdens, improve productivity, and assist with clinical decision-making.

For Abridge, the partnership offers access to Nvidia’s AI infrastructure while allowing the company to incorporate years of clinical expertise into the model.

Abridge brings medical data and expertise

Abridge plans to use de-identified clinical data gathered through its platform to further train and customize the model.

“Generic models are powerful, but clinical intelligence it still has to be trained, it has to be shaped, and it has to be evaluated against real-world conditions. That’s a lot of our early experiments and work with the Nemotron team,” said Dr. Shiv Rao, Abridge’s co-founder and chief executive.

Founded in 2018, Abridge specializes in ambient-listening technology that records conversations between doctors and patients and automatically generates clinical notes.

The company raised $300 million last year in a funding round that valued it at $5.3 billion, underscoring investor enthusiasm for healthcare AI applications.

The new model is expected to become one of several AI systems powering Abridge’s platform when it launches later this year.

According to Davis Liang, Abridge’s director of applied science, the company previously developed its own speech-recognition model because existing third-party systems were not optimized for hospital environments and medical terminology.

Cost efficiency is another factor driving the partnership.

Liang said smaller, purpose-built open models are often less expensive than proprietary alternatives and can be deployed on Abridge’s own infrastructure.

Hospitals see potential beyond documentation

Healthcare providers are already exploring how the technology could evolve beyond note-taking.

Dr. Joon Lee, chief executive of Emory Healthcare, said the health system has rolled out Abridge’s platform to more than 3,000 physicians.

Lee believes increasingly sophisticated AI tools could eventually provide real-time support during patient consultations.

“The doctor-patient conversation is at the center of so much decision-making and information exchange,” Lee said.

“I’m excited about the possibility of intelligence coming more and more in real-time.”

As healthcare becomes one of the most competitive frontiers for artificial intelligence, Nvidia’s latest partnership signals that the battle for medical AI leadership is only beginning.

The post Nvidia teams up with Abridge to build AI model for healthcare: report appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Nvidia teams up with Abridge to build AI model for healthcare: report
next post
Column: Wall Street’s AI-fueled surge is running into resistance

related articles

Dow futures jump 130 points: 5 things to...

July 20, 2026

Micron stock up 3%, SanDisk gains 2.5%: what...

July 20, 2026

Moonshot AI pauses Kimi K3 subscriptions as demand...

July 20, 2026

Ryanair Q1 profit misses estimates as lower fares...

July 20, 2026

Top 4 catalysts for the FTSE 100 Index...

July 20, 2026

European stocks edge lower amid US-Iran tensions

July 20, 2026

QuantumScape stock: what could trigger its looming 15%...

July 20, 2026

Hang Seng Index jumps on China stimulus hopes...

July 20, 2026

Kospi Index slides as Samsung, SK Hynix sink;...

July 20, 2026

Asian markets wobble as $90 Brent turns tech...

July 20, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump-backed candidate survives grueling runoff, advances to high-stakes Senate race

    June 17, 2026
  • PANW stock is surging amid cybersecurity demand, but key risks remain

    June 30, 2026
  • Rubio puts entire world on notice against rise of ‘poisonous’ far-left terror ‘masked as equality’

    July 16, 2026
  • Shopify stock eyes breakout as bullish inverted H&S pattern takes shape

    July 2, 2026
  • Socialists launch radical platform to abolish the US Senate in bid to fundamentally transform America

    July 10, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (423)
  • Investing (944)
  • Stock (58)

Latest Posts

  • Historian blasts Smithsonian’s activism shift after first visit in over a decade: ‘Completely different place’

    August 4, 2026
  • Options pricing suggests Q2 earnings won’t salvage Adobe stock

    June 11, 2026
  • Corning stock falls: why are analysts backing the stock?

    July 7, 2026

Recent Posts

  • U.S. economic growth slowed unexpectedly in the second quarter as tariffs and Iran war cut into gains

    July 31, 2026
  • Capital culture war heats up as GOP lawmaker targets DC schools over Old Glory snub

    July 30, 2026
  • U.S. suspends avocado inspections in Mexican state of Michoacan due to threat

    August 6, 2026

Editor’s Pick

  • Why SpaceX stock is down another 2% today

    July 16, 2026
  • Chip Roy fields proposal to block pay and power for longtime lawmakers

    June 11, 2026
  • Is Papa Murphy’s in trouble as up to 50 pizza stores face closure?

    July 14, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock